HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congressional Research Suggests Additional Layer Of Complexity In FDA’s Cannabinoid Puzzle

Executive Summary

Congressional Research Service report says in addition to markets for hemp from fiber, seeds and flowers, “a separate, marketable category exists for the plant’s extracted compounds.” Ingredients from hemp seeds and grains as well as from flowers are alternative protein sources in supplements, foods and beverages and dairy alternatives.

You may also be interested in...



Tasting Growth First With Hemp And Cannabis Ingredients, SōRSE Is Hungry For More Markets

SōRSE uses proprietary water-soluble emulsion technology to blend cannabinoids into ingredients its customers use in supplements, food and beverages and topicals. Cannabinoids it works with include THC and it also offers its own cannabis-infused beverage brands.

US House Appropriators Have Little Left To Say About Allowing Cannabinoids In Supplements

Appropriation Committee’s report with FDA’s FY2022 funding bill appears to signal that other than getting something done, members have little to say about establishing lawful use of hemp-derived cannabinoids in non-drug products.

Science-Based THC Limits ‘Urgently Needed’ For EU To Compete In Global CBD Market

“We urgently need the adoption of an EU wide regulation on sound scientific THC limits in food,” insisted EIHA president and Hempro International CEO Daniel Kruse at the association's 18th annual conference, “Hemp for Europe: Emerging opportunities for the Green Recovery.”

Related Content

Topics

UsernamePublicRestriction

Register

RS151520

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel